Anzeige
Mehr »
Login
Samstag, 02.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 920766 | ISIN: US0431132085 | Ticker-Symbol:
NASDAQ
01.11.24
20:43 Uhr
33,315 US-Dollar
-0,195
-0,58 %
Branche
Versorger
Aktienmarkt
Sonstige
1-Jahres-Chart
ARTESIAN RESOURCES CORPORATION Chart 1 Jahr
5-Tage-Chart
ARTESIAN RESOURCES CORPORATION 5-Tage-Chart
GlobeNewswire (Europe)
200 Leser
Artikel bewerten:
(1)

Artesian Resources Corporation Reports 2023 Year-End Earnings and Fourth Quarter Results

NEWARK, Del., March 13, 2024 (GLOBE NEWSWIRE) -- Artesian Resources Corporation (Nasdaq: ARTNA), a leading provider of water and wastewater services, and related services, on the Delmarva Peninsula, today announced earnings results for the fourth quarter and year ended December 31, 2023.

Year End Results

Net income was $16.7 million, a $1.3 million, or 7.2%, decrease compared to net income recorded during the twelve months ended December 31, 2022. Diluted net income per share decreased to $1.67, compared to $1.90 for the same period in 2022.

Revenues totaled $98.9 million for both the year ended December 31, 2023 and December 31, 2022, respectively:

Water sales revenue increased $1.7 million, or 2.2%, primarily related to a temporary net rate increase of 7.50% of gross water sales placed into effect on November 28, 2023, as permitted under Delaware law, until permanent rates are determined by the Delaware Public Service Commission, or DEPSC, and an increase in overall water consumption. In addition, fixed fee revenue increased as a result of additional customers.

Other utility operating revenue increased approximately $0.7 million, or 6.0%. This increase is primarily due to an increase in wastewater revenue associated with customer growth and an increase in fee revenue related to inspection, service and finance charges.

Non-utility operating revenue decreased approximately $2.4 million, or 26.9%. This decrease is primarily due to a decrease in contract service revenue related to a contract for the design and construction of wastewater infrastructure now nearing completion, partially offset by an increase in Service Line Protection Plan, or SLP Plan, revenue.

Operating expenses, excluding depreciation and amortization and income taxes, increased $0.2 million, or 0.4%.

Utility operating expenses increased $2.4 million, or 5.6%, primarily the result of increases in employee benefits and payroll costs, computer system maintenance costs, and supply and treatment costs for our water and wastewater systems. These increases are partially offset by a decrease in purchased water under a new contract, effective January 2022, in which the minimum amount of water required to be purchased was reduced.

Non-utility operating expenses decreased $2.4 million, or 35.4%, primarily due to a decrease in costs associated with a wastewater infrastructure design and construction contract.

Property and other taxes increased $0.2 million, or 3.9%, primarily due to an increase in utility plant subject to taxation and an increase in payroll taxes, related to increased payroll related expenses. Property taxes are assessed on land, buildings and certain utility plant, which include the footage and size of pipe, hydrants and wells.

Depreciation and amortization expense increased $0.7 million, or 5.7%, primarily due to continued investment in utility plant providing supply, treatment, storage and distribution of water to customers and service to our wastewater customers.

Federal and state income tax expense increased $0.5 million, or 8.0%, primarily due to adjustments related to the application of state net operating loss valuation allowances and stock options exercised in 2022, partially offset by lower pre-tax income in 2023 compared to 2022.

Other income increased $0.8 million, primarily due to a $0.7 million increase in allowance for funds used during construction, or AFUDC, as a result of higher long-term construction activity subject to AFUDC. Miscellaneous income increased $0.1 million primarily related to an increase in the annual patronage refund from CoBank, ACB. The primary refund calculation for both 2023 and 2022 was based on the average loan balance outstanding.

Long-term debt interest increased $0.5 million, primarily related to an increase in long-term debt interest associated with the Series W First Mortgage Bond issued on April 29, 2022. Short-term debt interest increased $0.1 million, primarily related to higher interest rates.

"In April 2023 we filed a request for an increase in water rates in our Delaware operations. We requested a $16.7 million increase in annual revenue, which is necessary to recover increased operating costs and significant investments made to ensure water quality and resiliency, including upgrades of our treatment equipment and facilities, new elevated water storage, replacement of aging water mains, and investments in information technology. We began charging temporary rates on November 28, 2023, as permitted by the Delaware Public Service Commission, while the full request is under examination. We are now beginning to see recovery of some of these investments and increased expenses," said Dian C. Taylor, CEO.

Fourth Quarter Results

Net income was $3.5 million for the three months ended December 31, 2023, a $1.2 million, or 49.7%, increase compared to net income recorded during the three months ended December 31, 2022. Diluted net income per share increased to $0.34 compared to $0.24 for the same period in 2022.

Revenues totaled $24.5 million, a decrease of $0.6 million, or 2.3%, compared to revenues recorded for the same period in 2022.

Water sales revenue increased $1.0 million, or 5.3%, primarily related to a temporary net rate increase of 7.50% of gross water sales placed into effect on November 28, 2023, as permitted under Delaware law, until permanent rates are determined by the DEPSC, and an increase in overall water consumption. In addition, fixed fee revenue increased as a result of additional customers.

Other utility operating revenue decreased approximately $0.1 million, or 3.5%, primarily due to decreased operating subsidies from developers and the timing of industrial wastewater revenue, partially offset by an increase in wastewater revenue associated with additional customers served.

Non-utility operating revenue decreased approximately $1.5 million, or 46.1%, primarily due to a decrease in contract service revenue related to a contract for the design and construction of wastewater infrastructure now nearing completion, partially offset by an increase in SLP Plan revenue.

Operating expenses, excluding depreciation and amortization and income taxes, decreased $2.3 million, or 13.9%.

Utility operating expenses decreased $1.1 million, or 8.3%, primarily the result of an overall decrease in payroll and employee benefits costs and water treatment costs.

Non-utility operating expenses decreased $1.3 million, or 54.8%, primarily due to a decrease in costs associated with a wastewater infrastructure design and construction contract.

Property and other taxes increased $0.1 million, or 4.6%, primarily due to an increase in utility plant subject to taxation and an increase in payroll taxes, related to increased payroll related expenses. Property taxes are assessed on land, buildings and certain utility plant, which include the footage and size of pipe, hydrants and wells.

Depreciation and amortization expense increased $0.2 million, or 5.6%, primarily due to continued investment in utility plant providing supply, treatment, storage and distribution of water customers and service to our wastewater customers.

Federal and state income tax expense increased $0.3 million, or 32.4%, primarily due to higher pre-tax income in 2023 compared to 2022.

Other income decreased $0.2 million, primarily due to a $0.1 million decrease in AFUDC, as a result of lower long-term construction activity subject to AFUDC.

Capital Expenditures

As part of Artesian's ongoing effort to ensure high-quality reliable service to customers, $62.2 million was invested in water and wastewater infrastructure projects during 2023 compared to $48.5 million for the same period in 2022. We invested in our rehabilitation program for transmission and distribution facilities by replacing aging or deteriorating mains, installation of new mains, enhancing or improving existing treatment facilities, construction of new water storage tanks, and replacing aging wells and pumping equipment to better serve our customers. We also continue to invest in wastewater treatment and distribution facilities.

"In 2023 we invested over $62 million in capital improvements. These investments in utility plant not only ensure that we provide high quality and reliable water and wastewater services to our customers, but allow us to meet growth demands in our expanding franchise area. Additionally, we continue to make investments proactively to treat for PFAS in drinking water in anticipation of the EPA's release of a more stringent regulation, staying ahead of the upcoming equipment supply needs of other utilities," said Nicki Taylor, President of Artesian Water Company.

About Artesian Resources
Artesian Resources Corporation operates as a holding company of wholly-owned subsidiaries offering water and wastewater services, and a number of other related core business services, on the Delmarva Peninsula. Artesian Water Company, the principal subsidiary, is the oldest and largest regulated water utility on the Delmarva Peninsula and has been providing water service since 1905. Artesian Water Company supplies 8.7 billion gallons of water per year through 1,470 miles of main to over a third of Delawareans.

Forward Looking Statements
This release contains forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding, among other things, recovery of investments in water utility plant and increased operating costs in rates charged to customers as presented in our current filing before the Delaware Public Service Commission, expectations regarding the cost, timing and recovery in customer rates of infrastructure investments and increased operational costs, our expectations in 2024, our ability to continue to provide high-quality and reliable water and wastewater service to customers and meet increased demands, and our growth strategy and continued growth in our business and the number of customers served. These statements involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements including: changes in weather, changes in our contractual obligations, changes in government policies, the timing and results of our rate requests, failure to receive regulatory approval, changes in economic and market conditions generally and other matters discussed in our filings with the Securities and Exchange Commission. While the Company may elect to update forward-looking statements, we specifically disclaim any obligation to do so and you should not rely on any forward-looking statement as representation of the Company's views as of any date subsequent to the date of this release.

Contact:
Nicki Taylor
Investor Relations
(302) 453-6900
ntaylor@artesianwater.com

Artesian Resources Corporation
Condensed Consolidated Statement of Operations
(In thousands, except per share amounts)
(Unaudited)
Three months ended Twelve months ended
December 31, December 31,
2023
2022
2023 2022
Operating Revenues
Water sales$19,739 $18,751 $80,033 $78,318
Other utility operating revenue 3,112 3,226 12,195 11,506
Non-utility operating revenue 1,694 3,140 6,633 9,073
24,545 25,117 98,861 98,897
Operating Expenses
Utility operating expenses 11,717 12,778 46,205 43,772
Non-utility operating expenses 1,099 2,432 4,428 6,850
Depreciation and amortization 3,453 3,270 13,335 12,620
State and federal income taxes 1,192 900 6,348 5,878
Property and other taxes 1,570 1,499 6,099 5,871
19,031 20,879 76,415 74,991
Operating Income 5,514 4,238 22,446 23,906
Allowance for funds used during construction 309 431 2,002 1,329
Miscellaneous (148) (47) 1,407 1,265
Income Before Interest Charges 5,675 4,622 25,855 26,500
Interest Charges 2,195 2,297 9,156 8,502
Net Income$3,480 $2,325 $16,699 $17,998
Weighted Average Common Shares Outstanding - Basic 10,281 9,497 10,018 9,462
Net Income per Common Share - Basic$0.34 $0.24 $1.67 $1.90
Weighted Average Common Shares Outstanding - Diluted 10,284 9,505 10,022 9,481
Net Income per Common Share - Diluted$0.34 $0.24 $1.67 $1.90
Artesian Resources Corporation
Condensed Consolidated Balance Sheets
(In thousands)
(Unaudited)
December 31, December 31,
2023
2022
Assets
Utility Plant, at original cost less
accumulated depreciation$714,284 $668,031
Current Assets 30,617 27,804
Regulatory and Other Assets 21,931 23,956
$766,832 $719,791
Capitalization and Liabilities
Stockholders' Equity$230,397 $187,930
Long Term Debt, Net of Current Portion 178,307 175,619
Current Liabilities 22,414 44,070
Net Advances for Construction 2,797 3,686
Contributions in Aid of Construction 247,934 224,308
Other Liabilities 84,983 84,178
$766,832 $719,791

© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.